SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-002704
Filing Date
2024-01-08
Accepted
2024-01-08 08:00:10
Documents
16
Period of Report
2024-01-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sprb-20240104.htm   iXBRL 8-K 67544
2 EX-99.1 sprb-ex99_1.htm EX-99.1 27319
3 EX-99.2 sprb-ex99_2.htm EX-99.2 38583
4 GRAPHIC img25151992_0.jpg GRAPHIC 8337
5 GRAPHIC img26075513_0.jpg GRAPHIC 8337
  Complete submission text file 0000950170-24-002704.txt   301277

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sprb-20240104_pre.xml EX-101.PRE 11578
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sprb-20240104_lab.xml EX-101.LAB 18691
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sprb-20240104.xsd EX-101.SCH 2501
10 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20240104_htm.xml XML 4901
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39594 | Film No.: 24518382
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)